NTRR
Price:
$0.0001
Market Cap:
$291.79K
Neutra Corp. specializes in the research, development, and provision of hemp-derived nutraceuticals. Its product portfolio features items such as CBD-infused sports creams, in addition to a variety of other health and wellness goods. Established in 2011, the company is headquartered in Sugar Land, Texas.
Industry
Biotechnology
IPO Date
2011-10-12
Stock Exchange
OTC
Ticker
NTRR
According to Neutra Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.43. This represents a change of -129.57% compared to the average of 1.45 of the last 4 quarters.
The mean historical PE Ratio of Neutra Corp. over the last ten years is -10.06. The current -0.43 PE Ratio has changed 327.57% with respect to the historical average. Over the past ten years (40 quarters), NTRR's PE Ratio was at its highest in in the July 2025 quarter at 4.20. The PE Ratio was at its lowest in in the April 2024 quarter at -17.84.
Average
-10.06
Median
-2.00
Minimum
-84.16
Maximum
2.00
Discovering the peaks and valleys of Neutra Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.58%
Maximum Annual PE Ratio = 2.00
Minimum Annual Increase = -4307.87%
Minimum Annual PE Ratio = -84.16
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | -84.16 | -4307.87% |
| 2025 | 2.00 | -166.67% |
| 2024 | -3.00 | 80.00% |
| 2023 | -1.67 | -30.56% |
| 2022 | -2.40 | -67.57% |
| 2021 | -7.40 | 2.58% |
| 2020 | -0.28 | 36.23% |
| 2019 | -0.20 | -91.32% |
| 2018 | -2.33 | 105.68% |
| 2017 | -1.13 | -209.05% |
The current PE Ratio of Neutra Corp. (NTRR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-28.39
5-year avg
-17.84
10-year avg
-10.06
Neutra Corp.’s PE Ratio is less than Bio-Path Holdings, Inc. (-0.06), less than Helix BioMedix, Inc. (-0.42), less than Unity Biotechnology, Inc. (-0.13), less than Orgenesis Inc. (-0.21), less than Biora Therapeutics, Inc. (-0.00), greater than Halberd Corporation (-14.31), less than Emmaus Life Sciences, Inc. (-0.08), less than Marizyme, Inc. (-0.00), greater than 4Cable TV International, Inc. (-16.90), less than Oxford Investments Holdings Inc. (-0.25),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.06 | $373.69K | |
| -0.42 | $229.20K | |
| -0.13 | $965.60K | |
| -0.21 | $2.07M | |
| -0.00 | $994.99K | |
| -14.31 | $464.29K | |
| -0.08 | $772.07K | |
| -0.00 | $39.54K | |
| -16.90 | $572.81K | |
| -0.25 | $71.96K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neutra Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neutra Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Neutra Corp.'s PE Ratio?
How is the PE Ratio calculated for Neutra Corp. (NTRR)?
What is the highest PE Ratio for Neutra Corp. (NTRR)?
What is the 3-year average PE Ratio for Neutra Corp. (NTRR)?
What is the 5-year average PE Ratio for Neutra Corp. (NTRR)?
How does the current PE Ratio for Neutra Corp. (NTRR) compare to its historical average?